Health Care Archives - Page 21 of 478

1 minute read

Contact Lens Maker Alcon’s Has New Growth Avenues, Analyst Upgrades Stock

May 15, 2:35 PM

Alcon's recent upgrades and promising opportunities, including the BELKIN Vision acquisition, expanding glaucoma treatment options, enhanced PanOptix IOL, and market advancements in China.

ALC

2 minute read

Takeda’s Dengue Vaccine Gets WHO Approval, Eligible for UN Procurement

By Vandana Singh

May 15, 2:02 PM

Takeda's dengue vaccine, Qdenga, gains WHO prequalification, enabling UN agency procurement. Approved in multiple countries, Qdenga is recommended for children 6-16 in high dengue areas.

SNY

1 minute read

What’s Going On With NVIDIA Stock Today?

By Nabaparna Bhattacharya

May 15, 12:53 PM

NVIDIA collaborates on ORBIT-Surgical, a simulation framework for training surgical robots, ahead of its debut at ICRA.

ISRG

2 minute read

No Wegovy Shortage in Denmark Amid High Demand, Novo Nordisk Confirms

By Vandana Singh

May 15, 11:59 AM

Novo Nordisk confirms there is no anticipated shortage of Wegovy in Denmark, despite prior warnings from the Danish Medicines Agency about limited supplies. The company addresses high demand and reassures the availability of all doses.

LLY

2 minute read

FDA Pushes Review Date For Ascendis Pharma’s Hormone Disorder Candidate By Three Months

By Vandana Singh

May 15, 11:57 AM

Ascendis Pharma announces FDA's extension of the review date for TransCon PTH for adults with hypoparathyroidism to August 14, 2024. TransCon PTH aims to address low calcium levels due to hypoparathyroidism.

ASND

2 minute read

Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound

By Vandana Singh

May 15, 10:03 AM

Eli Lilly has settled with Totality Medispa over counterfeit Mounjaro and Zepbound sales. The spa will pay damages and cease using Lilly branding. Corrective measures include compliance with federal law for tirzepatide products.

LLY

2 minute read

Employers Struggle with Drug Test Policies Amid Varying State Laws, Cheating on Drug Tests Reaches 30-Year High

By Vandana Singh

May 15, 8:37 AM

Cheating on drug tests among American workers has reached a 30-year high, with Quest Diagnostics Inc. reporting 31,000 tampered samples out of 5.5 million in 2023. The rise in synthetic urine use and additives, along with varying state marijuana laws, poses challenges.

DGX

1 minute read

On May 14, 2024, Paragon Therapeutics Announced A License Agreement Granting Spyre Therapeutics An Exclusive License To Certain Antibodies And Products Targeting α4SS7 Integrin And Tl1A, Paragon Will Up To $22M In Milestone Payments-8K

By Benzinga Newsdesk

May 15, 7:56 AM

Paragon will provide the Company with an exclusive license to its patents covering the related antibody, the method of use and its method of manufacture. Paragon will not conduct any new campaigns that generate

SYRE